GENTAMYCIN SULFATE

Gentamicin Sulfate, Betamethasone Valerate and Clotrimazole Otic Ointment, marketed as OTOMAX, is a veterinary pharmaceutical product prescribed for the treatment of acute and chronic otitis in canines. Each 15-gram tube contains 3 mg of gentamicin base, 1 mg of betamethasone valerate, and 10 mg of clotrimazole, formulated as a broad-spectrum antibiotic and antifungal combination. The item is packaged as a single unit of issue consisting of twelve 15-gram tubes, designated as one package. It must be stored at temperatures between 2°C and 25°C (36°F to 77°F) and is subject to a non-extendable shelf life of 24 months as a Type I (Code M) item under RS016 regulations. Packaging and marking must comply with the latest edition of the Medical Marking Standard No. 1 and MIL-STD-2073-1E, and all supplies must be labeled in accordance with DLA requirements. The item is regulated by the FDA, requiring a referral in EBS to a product specialist for confirmation prior to award, including bidder and manufacturer details. The NSN 6509-01-530-4283 applies to this item, with a delivery requirement of 89 days FOB destination, and no variance in quantity is permitted. The contract is issued under solicitation SPE2DP-26-T-3496, with a response deadline of May 26, 2026, and performance will be delivered to APO 09227-0000. The NAICS code 325412 identifies this as a pharmaceutical manufacturing activity under the Department of Defense’s Medical Supply Chain, and multiple approved manufacturers are listed, including Henry Schein Inc., Patterson Veterinary Supply, and Covetrus North America. This item is subject to RD003, indicating that covered defense information may apply, and procurement must adhere to DLA’s Master List of Technical and Quality Requirements referenced by RQ001 and RA001.